Cargando…
Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014–2019
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. The disability caused by inflammatory demyelination clinically dominates the early stages of relapsing-remitting MS and is reversible. Once there is considerable loss of axons, MS patients enter a seconda...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047782/ https://www.ncbi.nlm.nih.gov/pubmed/31960801 http://dx.doi.org/10.4103/1673-5374.272572 |